Tamsulosin Hydrochloride Capsule
Product Images NDC 71610-835

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 71610-835). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0835 30)

This text provides information about Tamsulosin HCI, USP in the form of 30 capsules. It includes the NDC# 71610-835-30, batch number, and suggested storage conditions.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Figure (Tamsulosin Fig1)

This is a figure representing the mean plasma concentrations of Tamsulosin Hydrochloride after the administration of Tamsulosin Hydrochloride Capsules 0.4 mg under fasted and fed conditions. The graph shows the plasma concentration (in ng/mL) over time (in hours) for a sample size of 8 individuals.*

FDA Label Image

Figure (Tamsulosin Fig2)

FDA Label Image

Figure (Tamsulosin Fig3)

FDA Label Image

Figure (Tamsulosin Fig4)

This is a description of the mean increase in peak urine flow rate in Study 1. The table shows the treatment with 2.54-8mg compared to placebo, with a mean change of 1.04 (musec). The duration of treatment in weeks is indicated as well.*

FDA Label Image

Figure (Tamsulosin Fig5)

FDA Label Image

Chemical Structure (Tamsulosin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.